PureTech Health plc (OTCMKTS:PTCHF) Sees Large Increase in Short Interest

PureTech Health plc (OTCMKTS:PTCHF) was the recipient of a significant growth in short interest in the month of February. As of February 15th, there was short interest totalling 47,400 shares, a growth of 1,723.1% from the January 31st total of 2,600 shares. Based on an average daily volume of 1,400 shares, the days-to-cover ratio is currently 33.9 days.

PureTech Health Price Performance

Shares of PureTech Health stock opened at $1.74 on Friday. The stock has a 50 day moving average price of $1.81 and a two-hundred day moving average price of $1.95. PureTech Health has a 12-month low of $1.66 and a 12-month high of $3.00.

About PureTech Health

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.